Lacipil

Medicinal product

(Invented) name

Lacipil

Active substance (s)

Lacidipinas

Strength

4 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C08CA09, Lacidipine

Marketing authorisation holder

GlaxoSmithKline Trading Services Limited, Airija

Date of authorisation

1995-02-15

Date of renewal

2007-05-04

Documents

0724 Lacipil 4mg tab II PL 2022 06 30.docx

0724 Pakuotės lapelis 4mg 2022 06 30.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Vienoje tabletėje yra	1 vnt.
Lacidipinas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
1354	2670	1002670	lizdinė plokštelė	N28		Receptinis	LT/1/95/0724/001	Netiekiama	-	-	No	-	-	Download
1355	2671	1002671	lizdinė plokštelė	N56		Receptinis	LT/1/95/0724/002	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2007-05-04	Perregistruotas
1995-02-15	Registruotas